Agenus Inc., a clinical-stage biotechnology company, discovers and develops therapies to activate the human body's immune technique from cancer and bacterial infections in America and internationally. It provides Retrocyte Display screen, an antibody expression platform for that identification of completely human and humanized monoclonal antibodies